{
  "docId": "019dd923-5e88-73ef-bd5d-cdf676789001",
  "docSlug": "1873217bba818632",
  "documentTitle": "2025 Bond Cap Artificial Intelligence AI 2025",
  "authorId": "BondCap",
  "authorName": "BOND",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "vc_research",
  "sourceTypeLabel": "VC research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.333,
  "pageNumber": 80,
  "pageCount": 340,
  "prevPage": 79,
  "nextPage": 81,
  "slideType": "impact_sizing",
  "function": "quantify_impact",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The chart highlights the efficiency gains of AI-driven drug discovery compared to traditional methods.",
  "elementsJson": [
    "headline_text",
    "bar_chart_vertical",
    "callout_box",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5d-cdf676789001/80",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5d-cdf676789001",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5d-cdf676789001.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5d-cdf676789001#slide-80",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.15,
        "x": 0.385,
        "y": 0.435
      },
      "kind": "callout",
      "text": "Traditional approaches can take 2.5-4 years",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b79dd75b-0ef9-45f4-a4d8-ac329da32427",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.65,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Months to Reach Pre-Clinical Candidate Status",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98e90753-88ba-4621-9aa9-8917f4919d49",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Months to reach pre-clinical candidate status: 30%-80%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-4e53-702a-8b88-6dd64ef9ac8a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.73,
        "y": 0.48
      },
      "kind": "quote",
      "text": "Pharma companies that use Cradle are seeing a 1.5x to 12x speedup in pre-clinical research and development by using our GenAI platform to engineer biologics. - Stef van Grieken, Co-Founder & CEO of Cradle, 5/25",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "efefd194-9f57-4408-9272-af15cc725603",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "Note: Pre-Clinical Candidate Status marks the point at which a lead molecule (or biologic) has satisfied all discovery-stage gates and is officially handed off to the development organization for work related to beginning human clinical trials. Figures collected from 2021-2024. Source: Cradle, Insilico Medicine via BioPharmaTrend, 'Insilico Medicine Reports Benchmarks for its AI-Designed Therapeutics' (2/25)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83ed5694-f5b8-400e-8f52-c5ae13ac1bfa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.96,
        "x": 0.02,
        "y": 0.02
      },
      "kind": "title",
      "text": "Research = 30%-80% Reduction in Medical R&D Timelines, per Insilico Medicine & Cradle",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "01b02721-6c2d-4216-9dfb-470346ac72c9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.24
      },
      "kind": "title",
      "text": "AI-Driven Drug Discovery – 2021-2024, Per Insilico Medicine, Cradle & BioPharmaTrend",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a01c162c-861f-4fd4-b15c-d17ffa4f4af3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 340,
      "from": 31,
      "beatId": "08b5f3f3-e96d-4460-a176-750933765cf7",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The deck concludes by encouraging action, providing guidance on navigating the AI landscape.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}